PI3K/AKT/mTOR and PD‑1/CTLA‑4/CD28 Pathways As Key Targets of Cancer Immunotherapy (Review)Shuangcui Wang, Changyu Liu,Chenxin Yang,Yutong Jin,Qian Cui,Dong Wang, Ting Ge, Guixin He,Wentao Li,Guan Zhang,Aqing Liu,Ying Xia,Yunhe Liu,Jianchun YuOncology letters（2024）引用 0|浏览5AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
